Search Results - "Foà’, Robin"
-
1
Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Published in The New England journal of medicine (23-06-2022)“…Until recently, Ph-positive ALL was very aggressive and difficult to treat. Current frontline therapy, based on tyrosine kinase inhibitors, glucocorticoids,…”
Get full text
Journal Article -
2
Can we cure Ph+ ALL without chemotherapy or transplant?
Published in Clinical advances in hematology & oncology (01-09-2024)Get full text
Journal Article -
3
Measurable residual disease in chronic lymphocytic leukemia. Where do we stand?
Published in Leukemia (01-12-2023)Get full text
Journal Article -
4
BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat?
Published in Cancer (15-01-2019)“…BCR/ABL1–like acute lymphoblastic leukemia (ALL) accounts for 15% to 30% of B‐lineage ALL, with a peak of incidence occurring in adolescence. This subgroup of…”
Get full text
Journal Article -
5
-
6
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Published in Advances in therapy (01-10-2017)“…Rituximab is a human/murine, chimeric anti-CD20 monoclonal antibody with established efficacy, and a favorable and well-defined safety profile in patients with…”
Get full text
Journal Article -
7
Childhood aggressive B‐cell non‐Hodgkin lymphoma in low–middle‐income countries
Published in British journal of haematology (01-02-2022)“…Summary In high‐income countries (HICs) paediatric aggressive B‐cell lymphomas are curable in about 90% of cases. Much worse results, with cure rates ranging…”
Get full text
Journal Article -
8
Minimal residual disease in Philadelphia‐positive acute lymphoblastic leukemia: Maximizing the clinical yield of testing
Published in American journal of hematology (01-08-2023)Get full text
Journal Article -
9
The evolution of frontline therapy for adult Philadelphia‐positive acute lymphoblastic leukemia: Giant strides and ongoing challenges
Published in American journal of hematology (01-03-2023)Get full text
Journal Article -
10
Introduction Chronic Lymphocytic Leukemia. Where Do We Stand, Where Do We Go
Published in The cancer journal (Sudbury, Mass.) (01-07-2021)Get full text
Journal Article -
11
Management of adult Ph-positive acute lymphoblastic leukemia
Published in Hematology (05-12-2015)“…Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) has been regarded for decades as the ALL subgroup with the worse outcome. It represents the most…”
Get full text
Journal Article -
12
Changes in the Treatment Landscape for Chronic Lymphoid Leukemia
Published in The New England journal of medicine (17-07-2014)“…After decades during which the treatment of patients with chronic lymphoid leukemia (CLL) was based on chemotherapy and more recently on chemoimmunotherapy, we…”
Get full text
Journal Article -
13
Treatment of relapsed/refractory paediatric aggressive B‐cell non‐Hodgkin lymphoma
Published in British journal of haematology (01-06-2020)“…Summary Aggressive B‐cell non‐Hodgkin lymphoma (B‐NHL) accounts for ≈60% of NHL in children/adolescents. In newly diagnosed Burkitt lymphoma and diffuse large…”
Get full text
Journal Article -
14
Gene mutations in lenalidomide-treated CLL
Published in Blood (19-04-2018)Get full text
Journal Article -
15
Ph-positive and ph-like all: how can we further improve?
Published in Hematology, Transfusion and Cell Therapy (01-10-2020)Get full text
Journal Article -
16
PSGL-1 decorated with sialyl Lewisa/x promotes high affinity binding of myeloma cells to P-selectin but is dispensable for E-selectin engagement
Published in Scientific reports (19-01-2024)“…Dissemination of multiple myeloma into the bone marrow proceeds through sequential steps mediated by a variety of adhesion molecules and chemokines that…”
Get full text
Journal Article -
17
Current Information and Recommendations on the Discontinuation of TKI Inhibitors in Chronic Myeloid Leukemia
Published in Current oncology reports (01-03-2018)“…Purpose of Review Discontinuation of tyrosine kinase inhibitors (TKIs) in chronic phase chronic myeloid leukemia (CP-CML) patients has become a reality…”
Get full text
Journal Article -
18
Another step forward in the 20-year history of IGHV mutations in chronic lymphocytic leukemia
Published in Haematologica (Roma) (01-02-2019)Get full text
Journal Article -
19
The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia
Published in Cancers (01-11-2023)“…Chronic lymphocytic leukemia (CLL) is a B-cell malignancy whose progression largely depends on the lymph node and bone marrow microenvironment. Indeed, CLL…”
Get full text
Journal Article -
20
Philadelphia‐positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID‐19 pandemic: a Campus ALL study
Published in British journal of haematology (01-07-2020)Get full text
Journal Article